Scientists uncover two Crohn’s disease subtypes using lab-grown intestines, offering hope for personalized therapies

Researchers used stem-cell derived organoids from Crohn’s disease patients to identify two molecular subtypes, paving the way for personalized treatments targeting specific disease characteristics.

CVS Health replaces CEO as it faces a range of challenges

CVS Health has replaced Karen Lynch with David Joyner as CEO, it said Friday, part of an attempt to turn the struggling company around. Joyner

October 18, 2024

Dual use of vapes and cigarettes hinders smoking cessation

People who use both vapes and cigarettes are less likely to quit compared to people who only smoke or only vape, according to a study

December 4, 2024

Alfasigma opens new doors in the US with Intercept acquisition – Pharmaceutical Technology

Alfasigma has acquired Ocaliva, a drug approved to treat primary biliary cholangitis, which is a condition where liver damage caused by a build-up of bile.

November 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.